Wall Street Analysts Predict a 75.79% Upside in Rigel (RIGL): Here's What You Should Know
Portfolio Pulse from
Wall Street analysts predict a significant upside of 75.8% for Rigel Pharmaceuticals (RIGL), based on average price targets. Positive earnings estimate revisions could support this potential increase.
January 17, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wall Street analysts have set an average price target for Rigel Pharmaceuticals (RIGL) that suggests a potential upside of 75.8%. This is supported by positive trends in earnings estimate revisions.
The article highlights a significant potential upside for RIGL based on analyst price targets, which is a strong indicator of positive sentiment. Additionally, the positive trend in earnings estimate revisions suggests that the company may perform better than expected, further supporting the potential for stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100